These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11030696)

  • 1. Family histories of cancer in primary care. Nurse led clinic may provide better service than computer program.
    Gray E; Rothnie N; Fowler A
    BMJ; 2000 Oct; 321(7266):955. PubMed ID: 11030696
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic risk assessment for breast and ovarian cancer.
    O'Rourke Tiffen J; Pfeifer K; Fishman DA
    Adv Nurse Pract; 2003 Oct; 11(10):40-8. PubMed ID: 14601495
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic testing for breast and ovarian cancer susceptibility: a family experience.
    Van Riper M; McKinnon WC
    J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of genetic testing for inherited breast and ovarian cancer risk.
    Calzone KA
    Nurs Spectr (Wash D C); 1998 Nov; 8(23):12-4. PubMed ID: 10542772
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of a cancer risk assessment clinic.
    Med Manag Netw; 1999 Jul; 7(7):6-10. PubMed ID: 10538699
    [No Abstract]   [Full Text] [Related]  

  • 6. Family histories of cancer in primary care. Referrals might be made on the basis of women's anxiety.
    Shere MH
    BMJ; 2000 Oct; 321(7266):955. PubMed ID: 11030695
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.
    Shah MR
    Mo Med; 2004; 101(2):105-10; quiz 110-1. PubMed ID: 15119107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D; Runowicz CD
    Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives.
    Friedenson B; Friedenson H
    MedGenMed; 2002 Aug; 4(3):3. PubMed ID: 12466746
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer genetics in primary care.
    Culler D; Grimes SJ; Acheson LS; Wiesner GL
    Prim Care; 2004 Sep; 31(3):649-83, xi. PubMed ID: 15331253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer susceptibility testing: past, present and future.
    Goldberg JI; Borgen PI
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1205-14. PubMed ID: 16925486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic testing in patients at risk for carcinoma of the breast].
    Kiechle M
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2420-2. PubMed ID: 17054060
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
    Wolff TA; Wilson JE
    Am Fam Physician; 2006 Nov; 74(10):1759-60. PubMed ID: 17137007
    [No Abstract]   [Full Text] [Related]  

  • 14. Women's decisions regarding management of breast cancer risk.
    MacDonald DJ
    Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary breast and ovarian cancer syndrome: should we test adolescents?
    Seeber B; Driscoll DA
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):161-7. PubMed ID: 15125901
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
    James PA; Harris M; Lindeman GJ; Mitchell G
    J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer. A risky business--assessing breast cancer risk.
    Levy-Lahad E; Plon SE
    Science; 2003 Oct; 302(5645):574-5. PubMed ID: 14576407
    [No Abstract]   [Full Text] [Related]  

  • 18. [In familial breast or ovarian carcinoma: normal cancer prevention is not enough].
    Riem L
    MMW Fortschr Med; 2004 Apr; 146(15):12. PubMed ID: 15373015
    [No Abstract]   [Full Text] [Related]  

  • 19. A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision.
    Friedenson B
    MedGenMed; 2001 Nov; 3(6):2. PubMed ID: 11965197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for hereditary breast and ovarian cancer: responsibility and choice.
    d'Agincourt-Canning L
    Qual Health Res; 2006 Jan; 16(1):97-118. PubMed ID: 16317179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.